A Smartphone Application for a Self-directed Upper Limb Therapy After Stroke
Launched by TAN TOCK SENG HOSPITAL · Jan 3, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new smartphone application designed to help people recover from upper limb difficulties after a stroke. Researchers want to see if using this app is as effective or better than a traditional hardcopy manual for guiding therapy at home. The trial will involve 80 participants who have had a stroke within the last four weeks. They will be divided into two groups: one will use the smartphone app, and the other will follow the hardcopy manual. Throughout the study, their progress will be checked at three different times to see how well they are recovering.
To participate, individuals must have a confirmed stroke diagnosis and be able to engage in tele-rehabilitation. They should also have a certain level of cognitive ability and some movement in their affected arm. However, those with severe pain, certain previous arm issues, or other health concerns may not be eligible. Participants can expect to follow a structured therapy program for four weeks, and their experiences with both the app and manual will be taken into account to determine which method is more helpful for recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of stroke (confirmed by CT/MRI scans)
- • ≤four weeks post-stroke
- • Montreal Cognitive Assessment (MOCA)\>=21
- • Finger extension Medical Research Council (MRC) \>=1
- • Fugl Meyer Upper Limb score \<60 or NIHSS Motor Arm section score\>=2
- • Potential discharge to home (able to do tele-rehabilitation for review)
- Exclusion Criteria:
- • Bilateral stroke
- • Montreal Cognitive Assessment (MOCA)\<21
- • Paretic upper limb numeric pain rating scale (NPRS)\>5
- • Reduced paretic upper limb use prior to stroke episode (e.g. frozen shoulder, fracture, etc)
- • Reduced paretic upper limb use due to orthopaedic problems such as fracture in existing stroke episode
- • Medically unstable
- • Neglect as ascertained by treatment team
- • Severe behavioural disturbance or agitation or epilepsy or untreated depression or psychiatric conditions
- • Pregnancy or lactation states
About Tan Tock Seng Hospital
Tan Tock Seng Hospital (TTSH) is a leading healthcare institution in Singapore, renowned for its commitment to excellence in patient care, education, and research. As a key player in the clinical research landscape, TTSH actively sponsors and conducts clinical trials across various medical specialties, aiming to advance medical knowledge and improve treatment outcomes. The hospital's robust infrastructure, multidisciplinary expertise, and strong collaborative ties with academic and research institutions enable it to facilitate innovative studies that adhere to the highest ethical and regulatory standards. Through its dedication to clinical research, TTSH strives to contribute significantly to the evolving field of medicine and enhance the health and well-being of the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported